Phcog.Net logo

BROWSE ALL JOURNALS

    SEE ALL 6 JOURNALS
    Article

    Use of topical brimonidine to prevent intraocular pressure elevations following Nd: YAG-laser posterior capsulotomy

    Deepika Singhal1★, Roopali Desai1, Sejal Desai1, Manisha Shastri1, Deepak Saxena1★ Corresponding author

    1. 1Department of Ophthalmology, Surat Municipal Institute of Medical Education and Research, Surat, Indian Institute of Public Health, Gandhinagar, India Research Paper.

    CORRESPONDENCE

    Deepika Singhal

    Department of Ophthalmology, Surat Municipal Institute of Medical Education and Research, Surat, Indian Institute of Public Health, Gandhinagar, India Research Paper.

    Volume 2, Issue 2 · pp. 104–106 · PUBLISHED 2011 · DOI: 10.4103/0976-500X.81902

    View on J Pharmacol. Pharmacother. original site ↗

    ABSTRACT

    Objective: To study the effect of brimonidine on intraocular pressure (IOP) following capsulotomy among Indian subjects. Materials and Methods: The study was a nonrandomized trial with open label. Results: 80% of the subjects showed a decrease in IOP after instilling 0.2% brimonidine (1 hour pre capsulotomy). No such decrease was observed in control. After 1 and 4 h post capsulotomy a statistically signifi cant decrease in IOP ranging between 1–10 mmHg was found in 73.3% of the treatment group. Conclusions: In the present study 0.2% brimonidine has been proven effective to counteract the increase in IOP following Nd-YAG laser capsulotomy in Indian setting.

    KEYWORDS

    Open in new tab

    REFERENCES

    As published

    Showing references and in-text citations exactly as published.

      Cite this article

      SELECT FORMAT

      Singhal, D., Desai, R., Desai, S., Shastri, M., & Saxena, D. (2011). Use of topical brimonidine to prevent intraocular pressure elevations following Nd: YAG-laser posterior capsulotomy. Journal of Pharmacology and Pharmacotherapeutics, 2(2), 104–106. https://doi.org/10.4103/0976-500X.81902